SLXN:NASDAQSilexion Therapeutics Corp Analysis

The moving-average structure behind Silexion Therapeutics Corp is bearish at $0.3697, with short-term averages lagging the long-term ones. It has lost 85.7% over the past 30 days. With RSI at 20.0 the momentum picture is oversold, alongside a bullish MACD signal. Watch $0.3500 as support and $1.99 as the nearer resistance level.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. The average analyst target implies 16129.4% above today's level.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 292.3%, a beta of 3.28 and a maximum drawdown of 99.5%, position sizing matters more than entry timing here. Thin trading volumes mean execution costs can be material on larger orders. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 3 out of 10.